sct1000
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 2, 2021 (NCT04921111)
Timeline
Indications
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05060484 | Phase 2 | Oct 19, 2021 | Government of China, Sinocelltech Ltd. |
| NCT04921111 | Phase 1 | Jul 2, 2021 | Sinocelltech Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sinocelltech Ltd. | For profit | 2 | 2 | 2 | 2021 |
| Government of China | Government | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1